Pharmaceutical Cannabis
Category: Medical · Level: Expert
Pharmaceutical cannabis refers to cannabis-derived medicines that meet pharmaceutical manufacturing standards and are prescribed through formal medical channels.
Pharmaceutical cannabis describes cannabis products manufactured to pharmaceutical (GMP) standards and administered through conventional medical pathways, including physician prescription and pharmacist dispensing. Examples include Epidiolex (FDA-approved CBD), Sativex (THC:CBD spray, approved in multiple countries for MS-related spasticity), Marinol and Syndros (synthetic THC/dronabinol). The pharmaceutical cannabis market is distinct from general medical cannabis programs, emphasizing clinical trial evidence, standardized dosing, established pharmacokinetics, and regulatory agency approval. The growth of pharmaceutical cannabis represents the highest tier of cannabis medicine development and is driving significant R&D investment.
Also known as
Cannabis medicine, Cannabinoid pharmaceutical
Usage
- Medical
- Legal
Related terms
- THC — Tetrahydrocannabinol (THC) is the primary psychoactive cannabinoid in cannabis, responsible for the 'high' associated with its use.
- Epidiolex — Epidiolex is the first FDA-approved prescription pharmaceutical containing purified CBD, indicated for rare childhood epilepsy syndromes.
- GMP — Good Manufacturing Practice (GMP) is a quality assurance framework mandated by regulatory agencies for the production of pharmaceutical, food, and cannabis products.
- CBD — Cannabidiol (CBD) is a non-psychoactive cannabinoid found in cannabis and hemp, widely used in medical research and consumer wellness products.
- Medical Cannabis — Medical cannabis refers to cannabis or cannabis-derived products prescribed or recommended by a licensed healthcare professional for therapeutic purposes.